226 related articles for article (PubMed ID: 2659288)
21. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
22. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
[TBL] [Abstract][Full Text] [Related]
23. Current state of infectious diseases--potential areas of directed therapy with aztreonam.
Neu HC
Am J Med; 1985 Feb; 78(2A):77-80. PubMed ID: 4038580
[TBL] [Abstract][Full Text] [Related]
24. Aztreonam in gram-negative infections in children.
Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
[No Abstract] [Full Text] [Related]
25. UTIs and two new antibiotics in the elderly.
Jones SR; Kimbrough R
Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
[TBL] [Abstract][Full Text] [Related]
26. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
[TBL] [Abstract][Full Text] [Related]
27. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
28. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
[TBL] [Abstract][Full Text] [Related]
29. Aztreonam.
Tunkel AR; Scheld WM
Infect Control Hosp Epidemiol; 1990 Sep; 11(9):486-94. PubMed ID: 2230052
[TBL] [Abstract][Full Text] [Related]
30. A comparison of monobactam antibiotics in surgical infections.
DiPiro JT; Bowden TA
Am J Surg; 1989 Jun; 157(6):607-14. PubMed ID: 2658643
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
Clergeot A; Steru D; Rosset MA; Carbon C
J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
[TBL] [Abstract][Full Text] [Related]
33. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
Albertazzi A; Bonadio M; Fusaroli M; Lotti T; Miano L; Salvia G; Sasdelli M; Villa G; Zucchelli P; Ventriglia L
Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293
[TBL] [Abstract][Full Text] [Related]
34. Aztreonam.
Childs SJ; Bodey GP
Pharmacotherapy; 1986; 6(4):138-52. PubMed ID: 3534798
[TBL] [Abstract][Full Text] [Related]
35. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
36. Comparative clinical evaluation of aztreonam versus aminoglycosides in gram-negative septicaemia.
Gudiol F; Pallarés R; Ariza X; Fernández-Viladrich P; Rufi G; Liñares J
J Antimicrob Chemother; 1986 May; 17(5):661-71. PubMed ID: 3722035
[TBL] [Abstract][Full Text] [Related]
37. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections.
Swabb EA; Cone CO; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S675-8. PubMed ID: 3909323
[TBL] [Abstract][Full Text] [Related]
38. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
39. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Rolston KV; Bodey GP; Elting L
Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
Torres A; de Celis R; Rabinad E; Marco F; Almela M; Deulofeu R; Rodriguez-Roisin R; Agusti Vidal A
Chemotherapy; 1989; 35 Suppl 1():15-24. PubMed ID: 2659289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
